Skip to main content

Advertisement

Table 1 Patient demographics

From: Upregulation of SLC2A3 gene and prognosis in colorectal carcinoma: analysis of TCGA data

  Discovery Set (TCGA, N = 345) Validation Set (GSE39582, N = 501)
Age, yr
 Median 67 68.1
 Interquartile range (55–75) (59–76)
Sex
 Female 157 (46%) 229 (46%)
 Male 188 (54%) 272 (54%)
AJCC TNM Stage
 I 54 (16%) 31 (6%)
 II 130 (38%) 244 (49%)
 III 111 (32%) 166 (33%)
 IV 50 (14%) 60 (12%)
Microsatellite instability
 MSI-L and MSS 291 (84%)  
 MSI-H 54 (16%)  
BRAF status
 V600E 50 (14%) 49 (10%)
 Wild-type 295 (86%) 452 (90%)
KRAS status
 Mutant 144 (42%) 198 (40%)
 Wild-type 201 (58%) 303 (60%)
OS event
 Event 78 (23%) 171 (34%)
 Non-event 267 (77%) 330 (66%)
OS months
 Median 31.4 56.5
 Range (0–147.9) (0–201)
DFS event
 Event 83 (24%) 150 (30%)
 Non-event 222 (64%) 346 (69%)
 Not available 40 (12%) 5 (1%)
DFS months
 Median 21 44
 Range (0–148) (0–201)